Wonder
Log in
Research Outline
Prepared for Jeffrey F. | Delivered May 8, 2020
Top Investors - Biotech
Review your project details
Goals
To provide a list of top active investors in biotech and their contact information, especially anyone who has made investments in COVID-19.
View less
Early Findings
Top investors by number of deals in 2019 and 2020:
Alexandria Venture
Investments (California):
19 deals
.
Felice Shieh
serves as the principal since April 2019.
Perceptive
A
d
v
i
s
o
r
s
(New York):
18 deals
.
Sam Chawla
is the portfolio manager and a member of the investment committee.
ARCH Venture
Partners (Illinois):
15 deals
.
Ari Nowacek
is the principal.
Google Ventures
(California):
15 deals
.
Terri C. Burns
is one of GV's principals.
Boxer Capital
(California):
14 deals
.
Dominik Naczynski
is the senior vice president at Boxer Capital.
OrbiMed
(New York)
: 14 deals
.
Conrad Wang
is the principal.
Redmile Group
(California):
14 deals
.
Jeremy Green
is the portfolio manager at Redmile.
Osage University
Partners (Pennsylvania):
12 deals
.
Stephanie Stehman
is the
principal of life science.
RA Capital Management
(Massachusetts):
12 deals
.
Matthew Hammond
is the principal at RA Capital.
Johnson & Johnson
Innovation (California and Massachusetts):
11 deals
.
Vijay Murthy
is the
principal
(venture investments) at Johnson & Johnson Innovation.
Covid-19
IndioBio
is investing in startups that are focused on developing “diagnostics, therapeutics, vaccines, disinfection, and other solutions addressing the worldwide problem of emerging infectious diseases.” Each startup is receiving
$250,000
from the life sciences startup incubator.
Biotech startup Cue Health secured a
$13 million contract
from the US Department of Health to develop and test a “handheld molecular test that can detect the presence of the SARS-CoV-2 novel coronavirus that causes COVID-19.”
View less